Furthermore, in agreement with PDLIM5 being a functional effector downstream of the HNRNPC–PABPC4 axis, PDLIM5 expression was also associated with survival of patients with breast cancer (Fig. 6h and Extended Data Fig. 6i,j). This evidence concerns the gene PDLIM5 and breast carcinoma.